Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2016-11-28
Summary
There are many bacteria that naturally live in our gut and are essential for good health. These bacteria have a variety of helpful functions, such as aiding digestion, synthesizing vitamins, repressing the growth of harmful bacteria and defending against some diseases. The desirable bacteria that live in the gut are collectively known as 'gut flora', or more appropriately, as 'gut microbiota'.
The less desirable resistant bacteria, however, can also be carried in a person's gut for prolonged periods of time and be found in the stools without causing illness. Persons that carry the resistant bacteria in the gut are known as "carriers" and they require no treatment. Knowing that a person carries resistant bacteria is helpful, because it will inform the choice of antibiotic if the person were to become unwell or had an intervention such as surgery in the future.
There is some evidence that resistant bacteria found in the stools can sometimes be passed from one person to another and eventually make someone ill if they infect (invade) their body. The investigators do not know how often this may happen, or how much carrying resistant bacteria in the stools may facilitate the spread of resistant bacteria in the population. It is important to address these questions and study ways to stop the resistant bacteria from spreading to safeguard the efficacy of antibiotics.
Conditions
- Gram-Negative Bacterial Infections
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
lead OTHER
Principal Investigators
-
Jonathan Edgeworth, MBBS · Guy's and St Thomas NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Human Microbiota in Healthy and Pathological Conditions
NCT03460392 ·Status: UNKNOWN
-
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04759001 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
NCT02031588 ·Status: TERMINATED
-
Prevalence of Digestive Carriage of Integrons
NCT01985217 ·Status: COMPLETED
-
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221 ·Status: COMPLETED
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
NCT00275327 ·Status: COMPLETED
-
Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research
NCT06466707 ·Status: RECRUITING ·Phase: NA
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
Impact of Prolonged Antibiotic Therapy on Commensal Microbial Community Gene Expression.
NCT05169255 ·Status: COMPLETED ·Phase: PHASE3
-
Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
NCT07093593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
NCT03350178 ·Status: TERMINATED ·Phase: PHASE2
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Multi-Antibiotic Resistance Carriage in Gut Flora
NCT01591538 ·Status: COMPLETED
-
Stool Transplantation to Reduce Antibiotic Resistance Transmission
NCT02461199 ·Status: UNKNOWN
-
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
NCT03967301 ·Status: UNKNOWN ·Phase: NA
-
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02840656 ·Status: COMPLETED
-
Gut Microbiota Pilot Study
NCT03897023 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NCT06782880 ·Status: RECRUITING ·Phase: NA
-
Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards
NCT00520715 ·Status: COMPLETED
-
Gut Microbiota Pilot Study
NCT03892590 ·Status: UNKNOWN
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06067386 ·Status: UNKNOWN ·Phase: NA
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING
-
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
NCT01703299 ·Status: COMPLETED